Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E. Sh. Ablyaeva"'
Autor:
D. P. Kamilova, M. M. Ovchinnikova, E. Sh. Ablyaeva, M. M. Leviashvili, N. S. Stuleva, E. V. Broitman, M. A. Ganikhina, E. N. Mayasina, L. F. Iskhakova, K. Yu. Boyarskiy, E. N. Ovsyannikova, Z. B. Barakhoeva, S. V. Nikitin, I. A. Bendusov, Yu. A. Fetisova, M. A. Yudina, E. S. Tararashkina, D. T. Khetagurova, D. V. Blinov, M. A. Polzikov
Publikováno v:
Акушерство, гинекология и репродукция, Vol 15, Iss 1, Pp 5-21 (2021)
Introduction. The efficacy and safety of biosimilar follitropin alpha have been demonstrated in randomized blinded prospective clinical trials of phases I and III. Unfortunately, there is a gap between the clinical trials and real clinical practice d
Externí odkaz:
https://doaj.org/article/661588ba396143dda53bf2d9330f5c39
Autor:
E. V. Broitman, I. A. Bendusov, D. P. Kamilova, M. A. Polzikov, E. S. Tararashkina, S. V. Nikitin, M. M. Ovchinnikova, E. Sh. Ablyaeva, N. S. Stuleva, M. A. Ganikhina, K. Yu. Boyarskiy, D. T. Khetagurova, E. N. Mayasina, E. N. Ovsyannikova, M. A. Yudina, D. V. Blinov, M. M. Leviashvili, Z. B. Barakhoeva, Yu. A. Fetisova, L. F. Iskhakova
Publikováno v:
Акушерство, гинекология и репродукция, Vol 15, Iss 1, Pp 5-21 (2021)
Introduction. The efficacy and safety of biosimilar follitropin alpha have been demonstrated in randomized blinded prospective clinical trials of phases I and III. Unfortunately, there is a gap between the clinical trials and real clinical practice d